DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dipper hypertensive patients

Hypertension Research

Volumn 36, Issue 2, 2013, Pages 166-171

  Gür, Mustafa ^a   Elbasan, Zafer ^a   Şahin, Durmuş Yildiray ^a   Yildiz Koyunsever, Nermin ^a   Şeker, Taner ^a   Özaltun, Betül ^a   Çayli, Murat ^a   Kocyigit, Abdurrahim ^b  

^a ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

antioxidant; dipper; DNA; hsCRP

Indexed keywords

ANTIOXIDANT; FREE RADICAL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; COMET ASSAY; CONTROLLED STUDY; DIPPER HYPERTENSION; DNA DAMAGE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON DIPPER HYPERTENSION; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE;

ADULT; ANTIOXIDANTS; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; DNA DAMAGE; FEMALE; HUMANS; HYPERTENSION; LYMPHOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84873527773     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.156     Document Type: Article

References (44)

1. Stokes 3rd J, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study-30 years of follow-up. Hypertension 1989; 13: 113-118.
2. O'Brien ET, Murphy J, Tyndall A, Atkins N, Mee F, McCarthy G, Staessen J, Cox J, O'Mally K. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens 1991; 9: 355-360.
3. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: systolic hypertension in Europe trial investigators. JAMA 1999; 282: 539-546.
4. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96-104.
5. Verdecchia P, Schillaci G, Porcellati C. Dippers versus non-dippers. J Hypertens 1991; 9: 42-48.
6. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kimura J. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke 1998; 29: 570-576.
7. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Satoh H, Hisamichi S. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997; 10: 1201-1207.
8. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. 'Non-dipper' hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995; 43: 382-387.
9. Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, Goto C, Oshima T, Chayama K, Yoshizumi M. Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers. J Am Coll Cardiol 2002; 40: 2039-2043.
10. Lassègue B, Griendling K. Reactive oxygen species in hypertension. An update. Am J Hypertens 2004; 17: 852-860.
11. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122: 339-352.
12. Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bächler JP. Relationship between oxidative stress and essential hypertension. Hypertens Res 2007; 30: 1159-1167.
13. Park YK, Lee SH, Park E, Kim JS, Kang MH. Changes in antioxidant status, blood pressure, and lymphocyte DNA damage from grape juice supplementation. Ann NY Acad Sci 2009; 1171: 385-390.
14. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, Corrocher R. Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267-1271.
15. Prabha PS, Das UN, Koratkar R, Sagar PS, Ramesh G. Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essent Fatty Acids 1990; 41: 27-33.
16. Dusting GJ, Akita K, Hickey H, Smith M, Gurevich V. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. Br J Pharmacol 1999; 128: 337-344.
17. Zicha J, Dobesova Z, Kunes J. Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 2001; 19: 247-254.
18. John S, Schmieder RE. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep 2003; 5: 199-207.
19. Harangi M, Remenyik EE, Seres I, Varga Z, Katona E, Paragh G. Determination of DNA damage induced by oxidative stress in hyperlipidemic patients. Mutat Res 2002; 513: 17-25.
20. Halliwell B, Aruoma O. DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Lett 1991; 281: 9-19.
21. Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR. Oxidative stress in humans: validation of biomarkers of DNA damage. Carcinogenesis 2002; 23: 1441-1446.
22. Subash P, Premagurumurthy K, Sarasabharathi A, Cherian KM. Total antioxidant status and oxidative DNA damage in a South Indian population of essential hypertensives. J Hum Hypertens 2010; 24: 475-482.
23. Collins AR, Olmedilla B, Southon S, Granado F, Duthie SJ. Serum carotenoids and oxidative DNA damage in human lymphocytes. Carcinogenesis 1998; 19: 2159-2162.
24. Stergiou GS, Salgami EV. World Health Organization-International Society of Hypertension (WHO-ISH); USA Joint National Committee on prevention, detection, evalutiaon, and treatment of high blood pressure (JNC-7); European Soceity of Hypertension-European Society of Cardiology (ESH-ESC). New European, American and International guidelines for hypertension management: agreement and disagreement. Expert Rev Cardiovasc Ther 2004; 2: 359-368.
25. Singh PN, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-191.
26. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
27. Chen LY, Nichols WW, Hendricks J, Mehta JL. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J 1995; 129: 211-218.
28. Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2-de-oxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res 2000; 24: 461-468.
29. Collins AR, Dusinska M, Gedik CM, Stetina R. Oxidative damage to DNA: do we have a reliable biomarker? Environ Health Perspect 1996; 4: 465-469.
30. Gedik CM, Wood SG, Collins AR. Measuring oxidative damage to DNA; HPLC and the comet assay compared. Free Radic Res 1998; 29: 609-615.
31. Møller P, Loft S. Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. Am J Clin Nutr 2002; 76: 303-310.
32. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004; 26: 249-261.
33. Maeda K, Yasunari K, Watanabe T, Nakamura M. Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure. Hypertens Res 2005; 28: 755-761.
34. Ermis N, Yagmur J, Acikgoz N, Cansel M, Cuglan B, Pekdemir H, Ozdemir R. Serum gamma-glutamyl transferase (GGT) levels and inflammatory activity in patients with non-dipper hypertension. Clin Exp Hypertens 2012; 34: 311-315.
35. Yildiz A, Gur M, Demirbag R, Yilmaz R, Akyol S, Aslan M, Erel O. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients. Clin Biochem 2008; 41: 779-784.
36. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC, Tsakiris D. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 2006; 48: 752-760.
37. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25: 155-161.
38. Landmesser U, Harrison DG. Oxidative stress and vascular damage in hypertension. Coron Artery Dis 2001; 12: 455-461.
39. Kario K. Vascular damage in exaggerated morning surge in blood pressure. Hypertension 2007; 49: 771-772.
40. Mü ller WU, Bauch T, Stü ben G, Sack H, Streffer C. Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay. Radiat Environ Biophys 2001; 140: 83-89.
41. Altindag O, Karakoc M, Kocyigit A, Celik H, Soran N. Increased DNA damage and oxidative stress in patients with rheumatoid arthritis. Clin Biochem 2007; 40: 167-171.
42. Baysal Z, Cengiz M, Ozgonul A, Cakir M, Celik H, Kocyigit A. Oxidative status and DNA damage in operating room personnel. Clin Biochem 2009; 42: 189-193.
43. Gur M, Yildiz A, Demirbag R, Yilmaz R, Koçyigit A, Celik H, Aksoy N. Increased lymphocyte deoxyribonucleic acid damage in patients with cardiac syndrome X. Mutat Res 2007; 617: 8-15.
44. Szeto Y, Lee A, Benzie I, Obied H. Optimized noninvasive procedures to measure DNA damage in comet assay. Hum Exp Toxicol (e-pub ahead of print 31 May 2012; doi: 10.1177/0960327112446816).